Spectrum Pharma (SPPI) Tops Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. BA
4. STX
5. NXPI
6. CSGP
7. LSTR
8. UPS
9. KIDS
10. V

Go back to Spectrum Pharma (SPPI) Tops Q4 EPS by 3c

Spectrum Pharmaceuticals Reports Fourth Quarter 2019 and Full Year 2019 Financial Results and Pipeline Update

February 27, 2020 4:00 PM EST

BLA for ROLONTIS® (eflapegrastim) accepted for FDA review - PDUFA date on October 24, 2020

Data from poziotinib Cohort 1 of ZENITH20 accepted for podium presentation on March 18 at 11th Annual Congress on Pulmonary and Respiratory Medicine in Amsterdam

Spectrum plans to hold a conference call following the data presentation to review the data and strategy of the program

HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced... More